The death of the Antioquian neurologist was announced Francisco Lopera Restrepofounder of the Antioquia Neuroscience Group, professor and researcher at the University of Antioquia for several years. He had retired from academic life a few months ago. He dedicated his career to Alzheimer’s research.
The Neuroscience Group of Antioquia confirmed the news of the death with the following message:
“It is with deep sadness that we inform you of the passing of our beloved mentor and founder, Dr. Francisco Lopera Restrepo. His passing leaves us with an immense void, not only for his invaluable scientific contribution, but also for his human warmth, his unwavering commitment to research and his passionate dedication to the well-being of patients and their families. We join in mourning with his family and loved ones.”
For its part, the University of Antioquia published the following:
“With profound sadness, admiration and gratitude, we at the UdeA say goodbye today to an invaluable human being, a rigorous professional, an inspiring professor and a curious and creative researcher who paved the way in the fight against Alzheimer’s. Thank you forever, Dr. Lopera!”
In its message, the UdeA also pledged to “continue his inspiring legacy.”
“From the University, which was his home and to which he gave great contributions, we will keep his name high.”
Sources from the academy confirmed to this publishing house that Professor Francisco died from a metastatic tumor in the brain. For this reason he faced a delicate state of health for several months.
A little about who Francisco Lopera Restrepo was
According to data from the UdeA, caregivers of patients with Alzheimer’s disease called him their “angel and hero.” In addition to his research, for 40 years, Francisco Lopera Restrepo managed to train scientific peers and generations of professionals; his legacy remains intact in the Neurosciences Group of Antioquia.
Read also: Dr. Francisco Lopera received the Nobel Prize for Alzheimer’s research
Lopera Restrepo focused his studies on identifying, studying and supporting people and families who suffer from the so-called “Paisa mutation” of early Alzheimer’s, a promising scientific discovery.
He had recently been recognized with the prestigious award Potamkin Prize for Research in Pick’s, Alzheimer’s, and Related Diseasesawarded by the American Academy of Neurology and the American Brain Foundation, and considered the ‘Nobel Prize’ of neuroscience research.
2024-09-11 01:00:26